Serious adverse events that occurred in more than one patient in the palbociclib plus letrozole group were pulmonary embolism ( three -LSB- @ % -RSB- patients ) , back pain ( two -LSB- @ % -RSB- ) , and diarrhoea ( two -LSB- @ % -RSB- ) .